68Ga-NODAGA-E[c(RGDyK)]2

N/A

Report date: 2025/11/20 11:38:18

NME

Base Information

Drug Name68Ga-NODAGA-E[c(RGDyK)]2

Drug Alias NameN/A

ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agent +[5]

Mechanisms of ActionRadionuclide imaging enhancersPositron-emission tomography enhancers

TargetsNot applicable

Therapy Area/IndicationsMyocardial InfarctionMyocardial IschemiaNeuroendocrine Tumors

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesRigshospitalet

China Registration ClassN/A

Develop Information

Active CompaniesRigshospitalet

Inactive CompaniesN/A

Active IndicationsMyocardial IschemiaNeuroendocrine Tumors

Inactive IndicationsMyocardial Infarction

Other Information

ATC CodeN/A